Gene · 10735
Papers2,605
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,605
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging roles of cohesin-STAG2 in cancer. | Oncogene | 2025 | 39613934 | PubTator, text mining | PubMed |
| Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemia. | Blood Adv | 2025 | 39504561 | PubTator, text mining | PubMed |
| Traffic light at DSB-transit regulation between gene transcription and DNA repair. | FEBS Lett | 2025 | 39333024 | PubTator, text mining | PubMed |
| Untangling the loops of STAG2 mutations in myelodysplastic syndrome. | Leuk Lymphoma | 2025 | 39264305 | PubTator, text mining | PubMed |
| Blast phase of chronic myeloid leukemia presenting as early T-cell precursor acute lymphoblastic leukemia. | Am J Clin Pathol | 2025 | 39235991 | PubTator, text mining | PubMed |
| Adhesin Component Member STAG2 Enhances Cisplatin Tolerance in Colorectal Cancer Cells through the Epithelial-mesenchymal Transition Pathway. | Recent Pat Anticancer Drug Discov | 2025 | 38963118 | PubTator, text mining | PubMed |
| FET fusion oncoproteins disrupt physiologic DNA repair and create a targetable opportunity for ATR inhibitor therapy. | bioRxiv | 2025 | 37205599 | PubTator, text mining | PubMed |
| Targeted Therapy in Non-Muscle Invasive Bladder Cancer-Clinical Updates. | Arch Pharmacol Ther | 2024 | 40964450 | PubTator, text mining | PubMed |
| Real-world outcomes of newly diagnosed AML treated with venetoclax and azacitidine or low-dose cytarabine in the UK NHS. | Blood Neoplasia | 2024 | 40453057 | PubTator, text mining | PubMed |
| Identification of host factors for livestock and poultry viruses: genome-wide screening technology based on the CRISPR system. | Front Microbiol | 2024 | 39640855 | PubTator, text mining | PubMed |
| Discovery of KPT-6566 as STAG1/2 Inhibitor sensitizing PARP and NHEJ Inhibitors to suppress tumor cells growth in vitro. | DNA Repair (Amst) | 2024 | 39541712 | PubTator, text mining | PubMed |
| STAG2 loss in Ewing sarcoma alters enhancer-promoter contacts dependent and independent of EWS::FLI1. | EMBO Rep | 2024 | 39487368 | PubTator, text mining | PubMed |
| Establishment and characterization of a patient-derived metastatic extraskeletal Ewing sarcoma cell line ES-ZSS-1. | Hum Cell | 2024 | 39475964 | PubTator, text mining | PubMed |
| Molecular genetic characterization of myeloid neoplasms with idic(X)(q13) and i(X)(q10). | Front Oncol | 2024 | 39391249 | PubTator, text mining | PubMed |
| A STAG2-PAXIP1/PAGR1 axis suppresses lung tumorigenesis. | bioRxiv | 2024 | 39345539 | PubTator, text mining | PubMed |
| Prenatal diagnosis in fetal right aortic arch using chromosomal microarray analysis and whole exome sequencing: a Chinese single-center retrospective study. | Mol Cytogenet | 2024 | 39334424 | PubTator, text mining | PubMed |
| Clinicopathological characteristics and genetic features of young and senior Ewing sarcoma patients. | Diagn Pathol | 2024 | 39285408 | PubTator, text mining | PubMed |
| Prognostic impact of DTA mutation and co-occurring mutations in patients with myelodysplastic syndrome. | Mol Biol Rep | 2024 | 39278886 | PubTator, text mining | PubMed |
| Presence of triple positive driver mutations in JAK2, CALR and MPL in primary myelofibrosis: a case report and literature review. | Hematology | 2024 | 39268974 | PubTator, text mining | PubMed |
| Cohesin mutations in acute myeloid leukemia. | Leukemia | 2024 | 39251741 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10735/papers?page=8